fromwww.aljazeera.com
1 day agoKimberly-Clark to buy Tylenol maker Kenvue for $40bn
Kimberly-Clark is laying down $40bn to buy Kenvue in a massive deal that has puzzled some investors, as the maker of Tylenol struggles with weak sales, lawsuits and White House attacks linking its painkiller to autism. Shares of Kimberly-Clark dropped sharply after the Monday announcement as stockholders scrutinised the 46 percent premium being paid for the former Johnson & Johnson unit that has had a turbulent year.
Business